Want to see JP:4934 full AI Analyst Report?
4934 Stock Chart & Stats
¥593.00
¥1.00(0.16%)
At close: 4:00 PM EDT
¥593.00
¥1.00(0.16%)
Day’s Range― - ―
52-Week Range¥576.00 - ¥817.00
Previous CloseN/A
Volume12.90K
Average Volume (3M)9.04K
Market Cap
¥5.09B
Enterprise Value¥1.73B
Total Cash (Recent Filing)¥4.95B
Total Debt (Recent Filing)¥1.37B
Price to Earnings (P/E)14.0
Beta0.66
Next Earnings
Dec 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)41.74
Shares Outstanding8,720,534
10 Day Avg. Volume6,400
30 Day Avg. Volume9,036
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)0.76
Price to Sales (P/S)0.38
P/FCF Ratio40.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)24.1
Revenue Forecast (FY)¥14.60B
Bulls Say, Bears Say
Bulls Say
Manageable LeverageLow leverage and a sizable equity base reduce balance-sheet strain and provide a buffer while the company works through operational challenges. This resilience can support continued investment and help absorb weaker periods without the financial pressure associated with a highly debt-funded model.
Strong Gross MarginA gross margin of roughly 76% provides a substantial gross-profit base from which to cover operating costs and invest in the business. Maintaining this level of product economics could support future profitability if revenue stabilizes and management improves operating efficiency.
Return To ProfitabilityThe return to positive earnings in 2025 and 2026 shows that the business has regained profitability after the prior loss-making period. Although earnings remain modest, this recovery provides a stronger foundation for rebuilding returns if revenue and operating performance improve.
Bears Say
Multi-Year Revenue ContractionSeveral consecutive years of revenue decline indicate ongoing demand or scale pressure rather than a single-period setback. Continued contraction can limit operating leverage, weaken the base for earnings growth, and make it harder for the company to improve profitability sustainably.
Thin ProfitabilityThin net and EBIT margins leave limited room for execution mistakes, cost increases, or further sales weakness before profits are affected. The gap versus stronger 2021–2022 profitability also suggests that the recent earnings recovery has not yet restored the company’s prior operating strength.
Inconsistent Cash GenerationWeak 2026 cash conversion and earlier periods of negative operating or free cash flow raise concerns about the durability of reported earnings. Inconsistent cash generation can constrain internally funded investment, reduce financial flexibility, and make results more sensitive to working-capital swings.
Premier Anti-Aging Co., Ltd. News
4934 FAQ
What was Premier Anti-Aging Co., Ltd.’s price range in the past 12 months?
Premier Anti-Aging Co., Ltd. lowest stock price was ¥576.00 and its highest was ¥817.00 in the past 12 months.
What is Premier Anti-Aging Co., Ltd.’s market cap?
Premier Anti-Aging Co., Ltd.’s market cap is ¥5.09B.
When is Premier Anti-Aging Co., Ltd.’s upcoming earnings report date?
Premier Anti-Aging Co., Ltd.’s upcoming earnings report date is Dec 11, 2026 which is in 58 days.
How were Premier Anti-Aging Co., Ltd.’s earnings last quarter?
Premier Anti-Aging Co., Ltd. released its earnings results on Sep 14, 2026. The company reported -¥20.45 earnings per share for the quarter.
Is Premier Anti-Aging Co., Ltd. overvalued?
According to Wall Street analysts Premier Anti-Aging Co., Ltd.’s price is currently Overvalued.
Does Premier Anti-Aging Co., Ltd. pay dividends?
Premier Anti-Aging Co., Ltd. does not currently pay dividends.
What is Premier Anti-Aging Co., Ltd.’s EPS estimate?
Premier Anti-Aging Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Anti-Aging Co., Ltd. have?
Premier Anti-Aging Co., Ltd. has 8,720,534 shares outstanding.
What happened to Premier Anti-Aging Co., Ltd.’s price movement after its last earnings report?
Premier Anti-Aging Co., Ltd. reported an EPS of -¥20.45 in its last earnings report. Following the earnings report the stock price went up 0.164%.
Which hedge fund is a major shareholder of Premier Anti-Aging Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order/EC, wholesale, and retail of cosmetics, health foods, and recovery wear in Japan. The company is involved in anti-aging and recovery businesses; and manufactures and sells skin care, hair care, and inner care products. It offers its products under the DUO, CANADEL, Clayence, C+mania, Sinto, Sitrana, Reinca, and Lalaskin brands. The company was incorporated in 2009 and is headquartered in Minato, Japan.
Technical Analysis
Ivy Cosmetics Corporation
―
HABA Laboratories, Inc.
―
C'BON COSMETICS Co., Ltd.
―
I-ne CO., LTD.
―
AXXZIA, Inc.
―